Search details
1.
Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer.
Cell
; 184(25): 6119-6137.e26, 2021 12 09.
Article
in English
| MEDLINE | ID: mdl-34890551
2.
Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal Adenocarcinoma.
Cell
; 181(4): 832-847.e18, 2020 05 14.
Article
in English
| MEDLINE | ID: mdl-32304665
3.
Multiplexed analysis of macrophage polarisation in pulmonary metastases of microsatellite stable colorectal cancer.
Cancer Immunol Immunother
; 73(3): 59, 2024 Feb 22.
Article
in English
| MEDLINE | ID: mdl-38386105
4.
Quantitative Multiplexed Analysis of Indoleamine 2,3-Dioxygenase (IDO) and Arginase-1 (ARG1) Expression and Myeloid Cell Infiltration in Colorectal Cancer.
Mod Pathol
; 37(4): 100450, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38369188
5.
Spatially resolved multimarker evaluation of CD274 (PD-L1)/PDCD1 (PD-1) immune checkpoint expression and macrophage polarisation in colorectal cancer.
Br J Cancer
; 128(11): 2104-2115, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37002343
6.
Immunological and prognostic significance of tumour necrosis in colorectal cancer.
Br J Cancer
; 128(12): 2218-2226, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37031328
7.
Prognostic significance of spatial and density analysis of T lymphocytes in colorectal cancer.
Br J Cancer
; 127(3): 514-523, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35449453
8.
Immune cell profiles in the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal cancer.
Cancer Immunol Immunother
; 71(4): 933-942, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-34529108
9.
TLR2 and TLR4 in colorectal cancer: relationship to tumor necrosis and markers of systemic inflammation.
Neoplasma
; 69(6): 1418-1424, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36264772
10.
An integrated analysis of lymphocytic reaction, tumour molecular characteristics and patient survival in colorectal cancer.
Br J Cancer
; 122(9): 1367-1377, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32157241
11.
Platelet count, aspirin use, and characteristics of host inflammatory responses in colorectal cancer.
J Transl Med
; 17(1): 199, 2019 06 13.
Article
in English
| MEDLINE | ID: mdl-31196200
12.
The relationships between serum cytokine levels and tumor infiltrating immune cells and their clinical significance in colorectal cancer.
Int J Cancer
; 139(1): 112-21, 2016 Jul 01.
Article
in English
| MEDLINE | ID: mdl-26874795
13.
Clinical impact and network of determinants of tumour necrosis in colorectal cancer.
Br J Cancer
; 114(12): 1334-42, 2016 06 14.
Article
in English
| MEDLINE | ID: mdl-27195424
14.
A pan-cancer analysis shows immunoevasive characteristics in NRF2 hyperactive squamous malignancies.
Redox Biol
; 61: 102644, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36867945
15.
Bayesian risk prediction model for colorectal cancer mortality through integration of clinicopathologic and genomic data.
NPJ Precis Oncol
; 7(1): 57, 2023 Jun 10.
Article
in English
| MEDLINE | ID: mdl-37301916
16.
Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity.
Cancer Res
; 83(3): 441-455, 2023 02 03.
Article
in English
| MEDLINE | ID: mdl-36459568
17.
Smoking and Incidence of Colorectal Cancer Subclassified by Tumor-Associated Macrophage Infiltrates.
J Natl Cancer Inst
; 114(1): 68-77, 2022 01 11.
Article
in English
| MEDLINE | ID: mdl-34264325
18.
Spatial Organization and Prognostic Significance of NK and NKT-like Cells via Multimarker Analysis of the Colorectal Cancer Microenvironment.
Cancer Immunol Res
; 10(2): 215-227, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34937729
19.
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer.
Clin Cancer Res
; 28(23): 5167-5179, 2022 12 01.
Article
in English
| MEDLINE | ID: mdl-36129461
20.
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer.
Clin Cancer Res
; 27(16): 4574-4586, 2021 08 15.
Article
in English
| MEDLINE | ID: mdl-34112709